Bouiller, K.; Zayet, S.; Lalloz, P.-E.; Potron, A.; Gendrin, V.; Chirouze, C.; Klopfenstein, T.
Efficacy and Safety of Oral Fosfomycin-Trometamol in Male Urinary Tract Infections with Multidrug-Resistant Enterobacterales. Antibiotics 2022, 11, 198.
https://doi.org/10.3390/antibiotics11020198
AMA Style
Bouiller K, Zayet S, Lalloz P-E, Potron A, Gendrin V, Chirouze C, Klopfenstein T.
Efficacy and Safety of Oral Fosfomycin-Trometamol in Male Urinary Tract Infections with Multidrug-Resistant Enterobacterales. Antibiotics. 2022; 11(2):198.
https://doi.org/10.3390/antibiotics11020198
Chicago/Turabian Style
Bouiller, Kévin, Souheil Zayet, Paul-Emile Lalloz, Anaïs Potron, Vincent Gendrin, Catherine Chirouze, and Timothée Klopfenstein.
2022. "Efficacy and Safety of Oral Fosfomycin-Trometamol in Male Urinary Tract Infections with Multidrug-Resistant Enterobacterales" Antibiotics 11, no. 2: 198.
https://doi.org/10.3390/antibiotics11020198
APA Style
Bouiller, K., Zayet, S., Lalloz, P.-E., Potron, A., Gendrin, V., Chirouze, C., & Klopfenstein, T.
(2022). Efficacy and Safety of Oral Fosfomycin-Trometamol in Male Urinary Tract Infections with Multidrug-Resistant Enterobacterales. Antibiotics, 11(2), 198.
https://doi.org/10.3390/antibiotics11020198